8% CONVERTIBLE PROMISSORY NOTE DUE [•]Convertible Security Agreement • October 16th, 2017 • Premier Biomedical Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 16th, 2017 Company Industry JurisdictionTHIS 8% CONVERTIBLE PROMISSORY NOTE is one of three duly authorized and validly issued 8% Convertible Promissory Notes of Premier Biomedical Inc. (the “Company”), having its principal place of business at P.O. Box 31374, El Paso, TX 79930, designated as its 8% Convertible Notes due [•] (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).